Marc Ullman was quoted in a NutraIngredients-USA article, “Indictment handed down in Florida over sale of SARMs, steroids.” Six people and two companies were charged by federal prosecutors for allegedly selling drugs unapproved by the FDA as supplements.

“Some of these people seem to think, ‘What’s the worst that can happen to me? A warning letter?

Robert Iseman penned a Thought Leaders Corner column for Population Health News in which he makes suggestions regarding how healthcare organizations can manage the social determinants of health (SDOH) within their patient population.

Robert noted, among other things, “It is easy for a health system to get carried away in the world of SDOH. It is

HACKENSACK, NJ  – – Rivkin Radler LLP is pleased to announce that Nancy A. Del Pizzo, Jenna Gabay, and Gene Kang, have been named 2019 New Jersey Super Lawyers.  Del Pizzo was named a Top Rated Intellectual Property Litigation Attorney; and Gabay and Kang were named Rising Stars.

A partner in the firm’s Commercial Litigation;

Uniondale, New York – March 2019 – Evan H. Krinick, Managing Partner of Rivkin Radler LLP, has announced that Jennifer Abreu has joined the firm as an Associate.

Jennifer Abreu has joined the firm’s Compliance, Investigations & White Collar and Insurance Fraud Practice Groups.

Jennifer helps insurers prosecute civil lawsuits under the federal Racketeer Influenced and

On April 2, Marc Ullman, along with the EAS Consulting Group, will conduct a Dietary Supplement GMP Seminar to help firms prepare for increased FDA enforcement. Given by former FDA compliance officials and industry experts, this intensive training program will provide all the information needed to comply with the rules, covering the responsibilities of domestic and

On April 10, 2019, Marc Ullman and Steven Shapiro will be featured speakers at Supplyside East, presenting on the topic, “What Is the Regulatory Current State of Play with CBD?”

The pair will discuss the latest insights around regulatory issues related to cannabidiol at the international, national and local levels.

Supplyside East, which bills itself

Dr. Scott Gottlieb, who announced his plan to resign as FDA commissioner on March 5, 2019, had in the previous week just announced plans to develop a regulatory framework for CBD.

Marc Ullman spoke with Nutraingredients-USA about what might happen with the CBD initiative for the article entitled “Advocates hopeful that Gottlieb’s departure won’t derail

Long Island Business News hosted a roundtable discussion on the current state of the healthcare industry. Rivkin partners Robert Iseman and Benjamin Malerba were joined by Dr. Zeyad Baker, ProHEALTH Care Associates’ president and CEO; Jeffrey Kraut, executive vice president of strategy and analytics at Northwell Health; and Dr. Simon Prince, president and CEO of

On March 5, Geoffrey Kaiser and Casey Murphy will be speaking to the Huntington Rotary Club regarding, “The Legal Pitfalls of Running a Cash Business.”

Program description:

Small businesses need to be aware that certain conduct that might seem a smart business move to avoid taxes and increase profit, can be big problem and a

Marc Ullman was quoted in a NutraIngredients-USA article, “Stakeholders cautiously optimistic on Gottlieb’s proposal for info protection in NDI filings.” The comments made by the FDA Commissioner Scott Gottlieb, MD, on the NDI’s issue have made dietary supplement industry stakeholders sit up and take notice.

“I’m encouraged just in that it is good to hear